评估冠心病多基因风险评分的性能与一致性
该横断面研究纳入All of Us研究计划、Penn Medicine BioBank和UCLA ATLAS精准健康生物库中有电子健康记录和基因分型数据的参与者,计算48种冠心病多基因风险评分(PRS)。在人群水平预测性能相似的PRS在个体水平风险估计上一致性差,连续一致性ICC为0.373(95%CI 0.372-0.375),Light κ未超过0.56。
要点
- 在All of Us研究计划的171 095名参与者中计算了48种冠心病PRS,其中46种在人群水平预测性能实际等效。
- 20%的参与者在风险最高5%和最低5%中至少各有1个评分。
- 人群水平性能相似的冠心病PRS在个体水平风险估计上高度可变,连续一致性ICC为0.373(95%CI 0.372-0.375)。
核心结论
- 在人群水平性能相似的冠心病PRS在个体水平风险估计上高度可变,临床实施需要改进统计方法量化不确定性并向患者和临床医生传达这种不确定性。
研究设计与样本
- 横断面研究,纳入All of Us研究计划(AOU)、Penn Medicine BioBank(PMBB)和University of California, Los Angeles(UCLA)ATLAS Precision Health Biobank中有电子健康记录和基因分型数据的多样化背景参与者。
- 在171 095名AOU参与者中计算了48种冠心病PRS,平均(SD)年龄为56.4(16.8)岁,104 947名参与者(61.3%)为女性。
- 35 590名参与者(20.8%)与非洲参考人群遗传最相似,29 801名(17.4%)与混合美洲参考人群遗传最相似,100 493名(58.7%)与欧洲参考人群遗传最相似,其余与中南亚、东亚和中东参考人群遗传最相似。
- 17 589名参与者(10.3%)患有冠心病,153 506名参与者(89.7%)无冠心病。
- 在PMBB的41 193名参与者和ATLAS的53 092名参与者中进行了分析。
主要发现
- 当纳入现患冠心病模型时,46种评分的Brier评分和受试者工作特征曲线下面积实际等效(实际等效区域±0.02)。
- 20%的参与者在风险最高5%和最低5%中至少各有1个评分。
- 个体预测的连续一致性差(ICC,0.373 [95%CI,0.372-0.375])。
- 用于评估风险分配一致性的Light κ未超过0.56。
- 在PMBB和ATLAS参与者中的分析产生了不同的等效评分集合,这些集合同样缺乏个体水平一致性。
关键数值与推荐
- 人群水平预测性能相似的PRS通过比较现患冠心病模型的校准和区分度来识别。
- 个体水平一致性通过组内相关系数(ICC)和Light κ进行检验。
- 实际等效区域为±0.02。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Polygenic risk scores (PRSs) for coronary heart disease (CHD) are a growing clinical and commercial reality. Whether existing scores provide similar individual-level assessments of disease susceptibility remains incompletely characterized. OBJECTIVE: To characterize the individual-level agreement of CHD PRSs that perform similarly at the population level. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of participants from diverse backgrounds enrolled in the All of Us Research Program (AOU), Penn Medicine BioBank (PMBB), and University of California, Los Angeles (UCLA) ATLAS Precision Health Biobank with electronic health record and genotyping data. EXPOSURES: Polygenic risk for CHD from published PRSs and new PRSs developed separately from testing samples. MAIN OUTCOMES AND MEASURES: PRSs that performed population-level prediction similarly were identified by comparing calibration and discrimination of models of prevalent CHD. Individual-level agreement was tested with intraclass correlation coefficient (ICC) and Light κ. RESULTS: A total of 48 PRSs were calculated for 171 095 AOU participants. The mean (SD) age was 56.4 (16.8) years. A total of 104 947 participants (61.3%) were female. A total of 35 590 participants (20.8%) were most genetically similar to an African reference population, 29 801 (17.4%) to an admixed American reference population, 100 493 (58.7%) to a European reference population, and the remaining to Central/South Asian, East Asian, and Middle Eastern reference populations. There were 17 589 participants (10.3%) with and 153 506 participants without (89.7%) CHD. When included in a model of prevalent CHD, 46 scores had practically equivalent Brier scores and area under the receiver operator curves (region of practical equivalence ±0.02). Twenty percent of participants had at least 1 score in both the top and bottom 5% of risk. Continuous agreement of individual predictions was poor (ICC, 0.373 [95% CI, 0.372-0.375]). Light κ, used to evaluate consistency of risk assignment, did not exceed 0.56. Analysis among 41 193 PMBB and 53 092 ATLAS participants yielded different sets of equivalent scores, which also lacked individual-level agreement. CONCLUSIONS AND RELEVANCE: CHD PRSs that performed similarly at the population level demonstrated highly variable individual-level estimates of risk. Recognizing that CHD PRSs may generate incongruent individual-level risk estimates, effective clinical implementation will require refined statistical methods to quantify uncertainty and new strategies to communicate this uncertainty to patients and clinicians.
引用
- Abramowitz SA, Boulier K, Keat K, et al. Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores. JAMA. 2025. PMID: 39549270. doi:10.1001/jama.2024.23784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。